Fellaz is also running a massive giveaway campaign, offering a chance to win $3,000 Beta Test Access and over 2,000 USDT in airdrop rewards. Follow @FellazXYZ and join now: ...

With the Cikande solar panels, Mowilex will lower its operational carbon footprint and cut non-renewable energy use by up to 25% per year. The company's new renewable energy project advances Indonesia ...

On night runs, runners wearing the 360X 2.0 "Acceleration" edition represent more than just visual impact—it reflects a mindset. "Acceleration" isn't just speed; it's a commitment to forward momentum ...

The Project is set to generate 16.7 million kilowatt-hours of green electricity annually and reduce carbon emissions by 14,000 tons. Serving as a pioneering initiative, it aims to promote floating ...

Andreas Tesch, currently Chief Market Officer (CMO), has been appointed as the new Chief Risk Officer (CRO). He replaces Christian van Lint, who is stepping down after a 42-year career at Atradius, ...

Donald Trump has announced that driving without a licence will become legal. OUR VERDICT. False. The US president has not ...

The inaccurate rumours refer to a study looking at excess deaths during the pandemic in the German city of Frankfurt am Main.

Fujitsu will continue to contribute to a sustainable world by enhancing resilience through the integration of data, AI technologies, and industry expertise, minimizing the impact on customers' ...

While Senior Level 1 psychiatrists receive a base full-time salary of $354,479 under those arrangements (p5), the 205 without ...

City Dialogues Vienna welcomed over 100 attendees from 20 countries; with representation from more than 20 universities and over 30 private and public organisations – a testament to the diversity and ...

A decade of cultivation culminates in today's brilliant finale, yet the journey ahead promises continued excellence! We cordially invite you to reunite in Shanghai from June 24-26, 2026, for another ...

ReCerf is the world's first commercially available ceramic HRA, first approved by Australia's Therapeutic Goods Administration in November 2024. Since its initial use in 2018, over 1,600 patients have ...